Streetbeat News

Stock Prices

LIQT

LiqTech International has announced a $10 million private placement transaction involving 3,630,129 shares of common stock and 1,369,871 pre-funded warrants with existing institutional investors.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 1:03 pm

AIM

AIM ImmunoTech Inc. has announced a registered direct offering of 4,653,036 shares at $0.27 per share, raising approximately $1.26 million. The company also issued unregistered warrants in a concurrent private placement.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 1:01 pm

KLAC

KLA (NASDAQ:KLAC) has been analyzed by 16 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target has increased by 4.77% to $866.12. KLA's financial performance is strong, with high revenue growth, net margin, ROE, and ROA, but a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 1:01 pm

FYBR

Analysts have mixed views on Frontier Communications (NASDAQ:FYBR) with recent ratings showing a bullish trend. The average 12-month price target has increased by 7.71% to $35.36. Despite positive revenue growth, the company faces challenges with profitability and debt management.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 1:00 pm

CMG

34 analysts have shared their evaluations of Chipotle Mexican Grill (NYSE:CMG) over the past three months, showing a mix of bullish and bearish perspectives. The average 12-month price target has decreased significantly, indicating a shift in sentiment. Despite this, Chipotle's financial health remains strong with impressive revenue growth, net margin, and return on equity.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 1:00 pm

KZR

Kezar Life Sciences shares have resumed trading after a temporary halt. This development is significant for investors monitoring the company's stock activity.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 1:00 pm

BRKR

In the past three months, four analysts have rated Bruker (NASDAQ:BRKR) with mixed sentiments ranging from bullish to bearish. The average 12-month price target has decreased by 9.75% to $72.5. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance. Bruker has shown strong financial performance with a 17.42% revenue growth rate, but its debt-to-equity ratio is higher than the industry average.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 1:00 pm

LXEH

Trading for LXEH was halted and then resumed, with updates provided at 8:55 AM ET. This indicates a temporary pause in trading, possibly due to pending news or volatility.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:55 pm

ABBV

ACN

DIS

META

On CNBC's 'Final Trades', analysts discussed Meta, Accenture, AbbVie, and Disney. Meta received a price target increase, Accenture reported strong earnings, AbbVie shared positive trial results, and Disney is expected to see higher streaming profitability despite layoffs.

Portfolio Pulse from Avi Kapoor

September 30, 2024 | 12:43 pm

CBNA

Chain Bridge Bancorp has announced its initial public offering (IPO) of 1.85 million shares, with an expected price range of $24 to $26 per share.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:38 pm